Skip to NavigationSkip to content

News

Lundbeck had big hopes for its drug candidate for Alzheimer's after positive Phase 2 results, and backed up its faith in the candidate with three...
Teva's current crisis has meant taking tough decisions, one such move seems to have been made by board members as they decided to cut their own pay...
AstraZeneca has announced that its drug Fasenra (benralizumab) has received approval from the European Commission (EC) as an adjuvant therapy in...
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, including pre-...
It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck KGaA’s consumer health business, allegedly...
Pressure is being placed on the government to increase funding levels to the service to ensure that it can be better prepared in the future to cope...
Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to...
A new project by researchers from Case Western Reserve University School of Medicine, funding by $2.8 million grant from the National Institute on...
Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge overturned the award to a...
In order to improve antiretroviral treatment adherence, researchers from Brigham and Women’s Hospital and MIT have designed a pill that can be taken...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches